Nature Reviews Drug Discovery

Journal

TitleNature Reviews Drug Discovery
ISSN1474-1776
PublisherNature Publishing Group

Outputs

Sort by: Date Title

Shouldn't enantiomeric purity be included in the minimum information about a bioactive entity? Response from the MIABE group

G - Articles in popular magazines and other technical publications
Orchard, S., Al-Lazikani, B., Bryant, S., Clark, D., Calder, E., Dix, I., Engkvist, O., Forster, M., Gaulton, A., Gilson, M., Glen, R., Grigorov, M., Hammond-Kosack, K. E., Harland, L., Hopkins, A., Larminie, C., Lynch, N., Mann, R. K., Murray-Rust, P., Lo Piparo, E., Southan, C., Steinbeck, C., Wishart, D., Hermjakob, H., Overington, J. and Thornton, J. 2012. Shouldn't enantiomeric purity be included in the minimum information about a bioactive entity? Response from the MIABE group. Nature Reviews Drug Discovery. 10, p. 661. https://doi.org/10.1038/nrd3503-c2

Minimum information about a bioactive entity (MIABE)

A - Papers appearing in refereed journals
Orchard, S., Al-Lazikani, B., Bryant, S., Clark, D., Calder, E., Dix, I., Engkvist, O., Forster, M., Gaulton, A., Gilson, M., Glen, R., Grigorov, M., Hammond-Kosack, K. E., Harland, L., Hopkins, A., Larminie, C., Lynch, N., Mann, R. K., Murray-Rust, P., Lo Piparo, E., Southan, C., Steinbeck, C., Wishart, D., Hermjakob, H., Overington, J. and Thornton, J. 2011. Minimum information about a bioactive entity (MIABE). Nature Reviews Drug Discovery. 10, pp. 661-669. https://doi.org/10.1038/nrd3503